Press Releases

 
Press Releases
  Date Title and Summary View
Aug 3, 2015
REDWOOD CITY, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that John A. Orwin, president and chief executive officer, will present at the 2015 Wedbush PacGrow Healthcare Conference on August 11, 2015 at 9:45 a.m. ET. To access the live webcast and subsequent archived recording of this presentation, p...
Jul 24, 2015
REDWOOD CITY, Calif., July 24, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on July 15, 2015, the compensation committee of the company's board of directors granted six new employees options to purchase an aggregate of 32,900 shares of the company's common stock with a per share exercise pr...
Jul 14, 2015
Patiromer FOS significantly decreased blood potassium levels in patients with chronic kidney disease and hyperkalemia at four weeks (primary endpoint) Potassium levels were maintained at normal levels through 52 weeks of treatment Patiromer FOS was well tolerated when used chronically and the safety profile was consistent with t...
Jul 2, 2015
REDWOOD CITY, Calif., July 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on July 1, 2015, the compensation committee of the company's board of directors granted nine new employees options to purchase an aggregate of 32,200 shares of the company's common stock with a per share exercise pri...
Jul 1, 2015
REDWOOD CITY, Calif., July 1, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that John A. Orwin, president and chief executive officer, will present at the Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 at 11:45 a.m. ET. To access the live webcasts and subsequent archived recordings of these present...
Jun 22, 2015
REDWOOD CITY, Calif., June 22, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on June 15, 2015, the compensation committee of the company's board of directors granted seven new employees options to purchase an aggregate of 58,500 shares of the company's common stock with a per share exercise ...
Jun 10, 2015
REDWOOD CITY, Calif., June 10, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on June 1, 2015, the compensation committee of the company's board of directors granted eight new employees options to purchase an aggregate of 99,400 shares of the company's common stock with a per share exercise p...
Jun 2, 2015
REDWOOD CITY, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on May 15, 2015, the compensation committee of the company's board of directors granted five new employees options to purchase an aggregate of 22,400 shares of the company's common stock with a per share exercise pri...
May 26, 2015
REDWOOD CITY, Calif., May 26, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the appointment of Charlotte Arnold to the position of Vice President, Corporate Communications. Ms. Arnold joins Relypsa with more than 15 years of experience in corporate and product communications. "With our co...
May 15, 2015
REDWOOD CITY, Calif., May 15, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced multiple poster presentations at the 2015 Annual Scientific Meeting of the American Society of Hypertension (ASH), including a late-breaking poster highlighting new data on changes to aldosterone levels from the Phase 3 O...
Page:
1
... NextLast
= add release to Briefcase